podcast

Neuralink is conducting human trials for their brain implant and surgical robot. They are recruiting participants with limited hand functionality. The first participant experienced initial issues with the implant but saw significant improvements. Neuralink has faced controversy over animal testing methods. Despite promising results, commercial use may take over a decade due to safety and regulatory concerns. Welcome back to Tech Talk, everyone. Today, we have an exciting topic to discuss, Elon Musk's Neuralink and its recent advancements. Joining us is Dr. Emily Carter, a neuroscientist who's been closely following Neuralink's progress. Welcome, Dr. Carter. Thank you for having me. I'm thrilled to be here. So Neuralink recently announced that they're looking for a second participant for their human trials. Can you tell us more about this? Absolutely. Neuralink is currently conducting what's called the PRIME study, which focuses on the safety and functionality of their brain implant and the surgical robot used to place it. They are recruiting participants who have limited or no ability to use both hands due to spinal cord injury or else. Interesting. The first participant, Nolan Darbar, had some initial issues with the implant, right? Yes, that's correct. The implant's threads retracted initially, causing some performance issues. However, adjustments were made and Darbar reported significant improvements. He can now control a computer cursor with his brain, which is a huge milestone. Wow, that's incredible. But Neuralink has faced some controversy, especially regarding their animal testing practices. Can you shed some light on that? Yes, Neuralink has been scrutinized for its animal testing methods. There have been allegations of debilitating effects on test animals. While the company aims to redefine human capability and enhance interaction for people with severe disabilities, these ethical concerns cannot be ignored. It's a complex issue, for sure, but the potential benefits are also enormous. Imagine helping paralyzed individuals control devices or even helping blind people regain sight. Absolutely. The technology is groundbreaking. The implant includes 1024 electrodes distributed across 64 threads and is powered by a small battery that can be charged wirelessly. The possibilities are endless. So what's next for Neuralink? When can we expect to see this technology available for commercial use? Well, despite the promising initial results, commercial use clearance may take over a decade. Neuralink has ambitious plans, but they need to ensure the technology is safe and effective through rigorous testing and regulatory approvals. Got it. Well, thank you so much for joining us today, Dr. Carter. This has been a fascinating discussion. Thank you for having me. It was a pleasure.